Different qualifiers of AUS/FLUS thyroid FNA have distinct BRAF, RAS, RET/PTC, and PAX8/PPARg alterations
CONCLUSIONSBRAF and RAS mutations are associated with different AUS/FLUS qualifiers and hence have different risks of malignancy. Consequently, a hybrid molecular and morphological subcategorization system could improve the malignancy risk stratification of thyroid FNA samples diagnosed as AUS/FLUS. Cancer Cytopathol 2018. © 2018 American Cancer Society.
Source: Cancer Cytopathology - Category: Pathology Authors: Claudio Bellevicine, Roberta Sgariglia, Ilaria Migliatico, Elena Vigliar, Melania D'Anna, Maria Antonia Nacchio, Nicola Serra, Umberto Malapelle, Massimo Bongiovanni, Giancarlo Troncone Tags: Original Article Source Type: research
More News: Cancer | Cancer & Oncology | Cytology | Fine Needle Aspiration | Pathology | Study | Thyroid | Thyroid Cancer